Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

28.83 +0.32 (+1.12%)

Streaming Delayed Price Updated: 9:58 AM EST, Feb 23, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	98,820
Open	28.16
Bid (Size)	28.66 (100)
Ask (Size)	28.96 (100)
Prev. Close	28.51
Today's Range	27.70 - 29.08
52wk Range	4.300 - 40.37
Shares Outstanding	45,711,975
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside? ↗

Today 4:04 EST

Capricor is approaching a regulatory filing timeline and earnings, while Sarepta heads into results under legal and safety pressure.

Via Stocktwits

Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today ↗

Today 3:37 EST

Data from Stocktwits indicated retail sentiment on SPY and QQQ has been ‘bearish’.

Via Stocktwits

Performance

YTD	+1.8%	+1.8%
1 Month	+24.3%	+24.3%
3 Month	+521.3%	+521.3%
6 Month	+336.8%	+336.8%
1 Year	+99.5%	+99.5%

More News

CAPR Stock Rallied Nearly 30% So Far This Week — Here’s The February FDA Catalyst Investors Are Betting On ↗

February 20, 2026

Via Stocktwits

‘Pharma Bro’ Martin Shkreli Goes Short On Capricor Therapeutics – Stock Tumbles 17% ↗

November 24, 2025

Via Stocktwits

Capricor Therapeutics Stock Jumps After-Hours As Retail Cheers Fresh FDA Attempt After Duchenne Therapy Rejection ↗

November 10, 2025

Via Stocktwits

Tesla Chair Declares Start Of 'Whole New Book' As Musk's 423 Million Share Award Is Locked In — All Hope Pinned On Robotaxi, Optimus ↗

November 10, 2025

Via Stocktwits

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

CAPR Stock Slides After FDA Requests More Data For Genetic Disorder Therapy — What Does Retail Think? ↗

January 20, 2026

Via Stocktwits

Here's Why This Biotechnology Skyrocketed by 439% in December ↗

January 09, 2026

Via The Motley Fool

On Friday, there are stocks with unusual volume. Let's take a look. ↗

December 05, 2025

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

December 04, 2025

Via Chartmill

Preview: Capricor Therapeutics's Earnings ↗

November 07, 2025

Via Benzinga

Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire ↗

December 04, 2025

Via Stocktwits

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

Via MarketMinute

‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win ↗

December 03, 2025

Via Stocktwits

Why Did Capricor Therapeutics Stock Skyrocket Today? ↗

December 03, 2025

Via Stocktwits

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

December 03, 2025

Via Chartmill

Nasdaq, S&P 500 Futures Point To Steady Open: Why CAPR, MRVL, AEO, GTLB, CRWD Are On Traders' Radar ↗

December 03, 2025

Via Stocktwits

Capricor Therapeutics Stock Sparks Retail Frenzy As Traders Hail ‘Best Data’ Ahead Of DMD Data Readout ↗

December 01, 2025

Via Stocktwits

Which stocks are experiencing notable movement on Monday? ↗

November 24, 2025

Via Chartmill

Top movers in Monday's session ↗

November 24, 2025

Via Chartmill

Top Stocks With Earnings This Week: Plug, Oklo, Circle And More ↗

November 10, 2025

Via Benzinga

Capricor Therapeutics Stock Becomes Talk Of Retail Town On DMD Study; Retail Sees New Hope After Sarepta Setback ↗

November 04, 2025

Via Stocktwits

CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Why Capricor Therapeutics Stock Is Surging Today ↗

September 25, 2025

Via Benzinga

Frequently Asked Questions

Is Capricor Therapeutics, Inc. - Common Stock publicly traded?

Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?

Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?

The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market

What is the current price of Capricor Therapeutics, Inc. - Common Stock?

The current price of Capricor Therapeutics, Inc. - Common Stock is 28.83

When was Capricor Therapeutics, Inc. - Common Stock last traded?

The last trade of Capricor Therapeutics, Inc. - Common Stock was at 02/23/26 09:58 AM ET

What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?

The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 1.32B

How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?

Capricor Therapeutics, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.